Luke Halpern is an assistant editor with Pharmacy Times. Luke wrote for Pharmacy Times in the summer of 2023, and assumed a full-time role in June 2024. His work has been featured in Pharmacy Times and the American Journal of Managed Care. He graduated from the University of Massachusetts, Amherst in May 2024.
Case Study: Intravenous Immunoglobulin Infusion Effectively Treats Parvovirus B19 Infection
August 10th 2023After repeated treatment with packed red blood cell transfusions, treatment with intravenous immunoglobulin in a child with parvovirus B19 infection successfully resolved the infection and negated the need for further transfusions.
Read More
Predictive Model for Cervical Cancer Improved With Inclusion of Human Papillomavirus Genotypes
August 9th 2023Adding human papillomavirus genotypes to the predictive model had a significantly higher effect in improving accuracy compared to adding epidemiological factors and pelvic examination.
Read More
Nose Picking Among Health Care Workers Associated With Increased Risk of SARS-CoV-2
August 8th 2023Study results showed no significant association between those who bite their nails and SARS-CoV-2 infection, in addition to a lower rate of infection for those who wear glasses compared to those who don’t wear glasses.
Read More
Exercise Can Improve Chemotherapy-Induced Peripheral Neuropathy in Patients With Ovarian Cancer
August 4th 2023The affect of an aerobic exercise program was more prevalent in patients with ovarian cancer who had at least 1 symptom of chemotherapy-induced peripheral neuropathy at the beginning of the trial.
Read More
Daily Low-Dose Aspirin Does Not Significantly Reduce Risk of Stroke, Can Cause Intracranial Bleeding
August 2nd 2023Study findings contrast with previously reported research linking aspirin to the secondary prevention of stroke, and are especially notable for older adults who may be more susceptible to bleeding-inducing events.
Read More
PrEP Services in Pharmacies Across Southeastern US Would Increase Treatment Capacity for HIV
August 1st 2023A new study revealed multiple locations across the southeast, including Georgia, Kentucky, and Florida, with areas that had high HIV risk but little-to-no preexposure prophylaxis services in the area.
Read More
Pembrolizumab Plus Chemotherapy Led to Pathological Complete Response in Patients with Breast Cancer
July 31st 2023The trial was recommended to continue to analyze event-free survival rates, but current results are encouraging for treating estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer.
Read More
Cap on Out-of-Pocket Insulin Costs in Inflation Reduction Act Increased Prescription Fills
July 28th 2023Thousands more people filled their insulin prescriptions following the introduction of the cap in January 2023, especially compared to those who were not enrolled in Medicare, a new study finds.
Read More
As Chemotherapy Drug Shortage Continues, Unimaginable Decisions and Lacking Accountability Reign
July 24th 2023Treatment providers have been forced to adapt and make potentially life-altering decisions for patients due to persistent chemotherapy drug shortages, all while solutions from the FDA and drug manufacturers remain scant.
Read More